Events

Videos

Podcasts

Articles

Gynecologic Oncology

The OncLive Gynecologic Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of gynecologic cancers, including ovarian cancer, endometrial cancer, and uterine cancer, among others. This section features news articles, interviews with gynecologic oncologists in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in gynecologic cancers.

Combinations With PARP Inhibitors for Ovarian Cancer 

Ovarian Cancer: Selecting an Appropriate PARP Inhibitor 

Ovarian Cancer: Treating Through Multiple Progressions 

Ovarian Cancer: Comparisons Between PARP Inhibitors 

PARP Inhibitors's Role as Maintenance Therapy in EOC

Ovarian Cancer: Optimizing Treatment With Niraparib

Treating Ovarian Cancer With Niraparib: The NOVA Trial 

Platinum-Sensitive Relapsed Ovarian Cancer: Rucaparib 

Value of Olaparib in BRCA-Mutated Advanced Ovarian Cancer 

PARP Inhibitors' Impact on Advanced Ovarian Cancer

Ovarian Cancer: Considerations for Molecular Testing   

Ovarian Cancer: Testing for Mutations 

Molecular Testing in Ovarian Cancer

Maurie Markman, MD, president of medicine and science, Cancer Treatment Centers of America, editor-in-chief, OncologyLive, discusses endpoints in clinical trials for ovarian cancer.

Dr. Markman on Endpoints in Clinical Trials for Ovarian Cancer

Jonathan Ledermann, MD, professor of medical oncology, UCL Cancer Institute, London, United Kingdom, discusses rucaparib (Rubraca) maintenance in ovarian cancer.

Dr. Ledermann on Rucaparib Maintenance in Ovarian Cancer

Soft Tissue Sarcoma: An Increasing Number of Options

Second-Line Therapy Options: Role of Trabectedin

Soft Tissue Sarcoma: Decisions Following Progression

Changing Treatment Landscape in Soft Tissue Sarcoma

Olaratumab's Role in Soft Tissue Sarcoma

The OncLive Ovarian Cancer condition center page is a comprehensive resource for clinical news and expert insights on ovarian cancer and evolving treatment approaches, including PARP inhibitors, antibody-drug conjugates, chemotherapy and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in ovarian cancer.

Ovarian Cancer

GSK-22-OSD1278 - /clinical/ovarian-cancer

Ovarian Cancer | Specialty